Genital Warts Ointment

When it comes to treating genital warts, there are several methods available that doctors may employ. However, there doesn't appear to be one type of treatment for genital warts to effectively treat every person that comes down with the disease. In the fight against genital warts, doctors have been performing plenty of research noting possible new treatments for the disease. In this article, we'll take a look at a new treatment that is being developed to give doctors another option when it comes to helping patients with genital warts.

Known as Polyphenon E, this new type of genital wart ointment was created by a bio-tech company known as MediGene AG, with the A-G part of the name representing the two countries involved in the research - America and Germany. Based in Frankfurt, the phase 3 trial of testing the drugs has already been completed, and MediGene couldn't be happier about the results. The trial was conducted with over 500 patients that had genital warts who were in 48 different hospitals in 7 different countries. The studying method that was employed for the test was double-blind, meaning that neither the physicians that were applying the treatment nor the patients that were receiving the treatment had absolutely no idea if they were getting the real Polyphenon E or a placebo. This type of study helps to eliminate the possibility of the placebo effect, in which a patient merely believes that a treatment is working, and through that, they feel better.

In the test, the Polyphenon E ointment was applied three times daily for up to sixteen weeks if necessary. The genital wart ointment itself is actually made of an extract that is found in the leaves that make up green tea. After the phase 3 test was complete, the results showed that a full fifty three percent of all the tested patients exhibited a complete lack of genital warts by the end of the sixteen weeks. In approximately seventy eight percent of all of the cases, most of the warts were removed. Less than five percent of all the test subjects experienced a recurrence of genital warts within the twelve weeks of follow-up questions posed by the research team.

Since the results of the phase 3 test showed to be of promise, MediGene AG is now planning on performing similar tests in the United States in order to gain approval for the drug. The bio-tech company also feels that the drug may be of merit in helping different problems with the skin as well, and they have figured the potential net earnings from the development of Polyphenon E to be in excess of one hundred million dollars. It's important to remember that the drug has not been completely cleared yet, and there may be some problems with it. However, if the drug is to meet the approval of the Food and Drug Administration of the United States, it may prove to be an effective tool in the arsenal of doctors who are waging war against genital warts.

Genital warts ointment news on the Web
HPV can cause other health problems such as genital warts. HPV is a common virus that is easily spread by skin-to-skin contact during sexual activity with another person. It is possible to have HPV without knowing it, so it is possible to unknowingly ...
Washington Post (blog)
Food Consumer

In real life, of course, we know that frogs don't cause warts. Unfortunately, princes -- or rather, the humans we kiss -- CAN give us warts. And not the type that are on the bottom of your little toe, either. Genital Warts are a sexually transmitted ...

Malaysia Star
GENITAL warts are fleshy growths found on or around the genitalia or anus. It is caused by the human papillomavirus (HPV), which is a common sexually transmitted infection. Genital warts are common, particularly in sexually active ...

WebMD (blog)
To protect against cervical cancer and genital warts, the HPV vaccine is recommended to be routinely given to girls at age 11 or 12, and can be given up to age 26 to those who did not get all doses when they were younger. Before HPV vaccines Gardasil ...
Daily Kos
 - -

RTT News
Veregen, for the topical treatment of external genital warts, contains a concentrate of catechins with a complex defined composition, extracted from green tea leaves. MediGene acquired the basic rights to the active ingredient in Veregen from the ...
Reuters (press release)

Malaysia Star
The human papilloma virus (HPV) vaccine which helps in the prevention of HPV infection, a leading causative factor of genital warts and cervical cancer, became available in 2006. Although Malaysia started its national HPV vaccination programme in 2010, ...
Chicago Tribune
New York Times

Cheney University Athletics
HPV also causes genital warts (warts on or around the penis, vagina, or anus). Yes, there are people who get warts in those areas, as well as cancer. Don't be one of them. Get the series of three shots of this vaccine, which is called Gardasil (its ...
CBS News

Other common surgeries include implants for men suffering erectile dysfunction and removal of genital warts. Here's the Empowered Patient list of questions every man should ask before having these procedures on this most valued and delicate of organs. ...

The vaccine protects against two high risk strains, those known to potentially cause cancer, and two low risk strains that typically result in genital warts. Since that time, the usefulness of the vaccine has expanded. The vaccine, which initially was ...
Chicago Sun-Times
USA Today
 - -

USA Today
Following extensive review and study, the FDA approved Gardasil in 2006 for use in females age 9 to 26 to protect against cervical, vulvar and vaginal cancers caused by human papillomavirus (HPV) and genital warts caused by HPV. ...

Google News